Gladius Capital Management LP - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 125 filers reported holding NUVATION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Gladius Capital Management LP ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$21,550
-7.1%
16,082
+24.8%
0.00%0.0%
Q2 2023$23,192
-2.3%
12,884
-9.9%
0.00%0.0%
Q1 2023$23,742
-36.5%
14,302
-26.6%
0.00%
-66.7%
Q4 2022$37,400
+24.7%
19,479
+47.3%
0.00%
+200.0%
Q3 2022$30,00013,2220.00%
Other shareholders
NUVATION BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 22,957,340$195,137,00027.59%
Aisling Capital Management LP 2,541,009$21,599,0007.62%
EDBI Pte Ltd 1,270,504$10,799,0005.87%
EcoR1 Capital, LLC 13,896,543$118,121,0003.76%
Ally Bridge Group (NY) LLC 1,197,152$10,176,0003.56%
Boxer Capital, LLC 4,341,009$36,899,0001.43%
Avidity Partners Management LP 7,382,488$62,751,0001.33%
Baupost Group 8,623,021$72,957,0000.72%
Abrams Capital Management 3,811,513$32,398,0000.71%
Redmile Group, LLC 3,671,009$31,204,0000.71%
View complete list of NUVATION BIO INC shareholders